L. Bras, J. Musset, L. Clain, and J. , Les r??sistances aux??m??dicaments antipaludiques, M??decine et Maladies Infectieuses, vol.36, issue.8, pp.401-405, 2006.
DOI : 10.1016/j.medmal.2006.05.005

N. White, Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 2001.
DOI : 10.1016/S1368-7646(98)80208-2

J. Ndiaye, F. B. Gueye, A. Tine, R. Ndiaye, D. Tchania et al., Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial, Malaria Journal, vol.10, issue.1, p.237, 2011.
DOI : 10.1111/j.1365-3156.2008.02119.x

S. Thiam, M. Thior, F. B. Diouf, M. Diouf, M. Diallo et al., Major Reduction in Anti-Malarial Drug Consumption in Senegal after Nation-Wide Introduction of Malaria Rapid Diagnostic Tests, PLoS ONE, vol.83, issue.4, p.18419, 2011.
DOI : 10.1371/journal.pone.0018419.t002

L. Gadiaga, V. Machault, F. Pagès, A. Gaye, F. Jarjaval et al., Conditions of malaria transmission in Dakar from 2007 to 2010, Malaria Journal, vol.10, issue.1, p.312, 2007.
DOI : 10.1603/0022-2585(2005)042[0104:COHCAO]2.0.CO;2

B. Cissé, C. Sokhna, D. Boulanger, J. Milet, E. Ba et al., Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial, The Lancet, vol.367, issue.9511, pp.659-667, 2006.
DOI : 10.1016/S0140-6736(06)68264-0

C. Sokhna, B. Cissé, E. Ba, P. Milligan, R. Hallett et al., A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children, PLoS ONE, vol.91, issue.1, p.1471, 2008.
DOI : 10.1371/journal.pone.0001471.s002

B. Cissé, M. Cairns, E. Faye, O. Ndiaye, F. B. Cames et al., Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children, PLoS ONE, vol.25, issue.1, p.7164, 2009.
DOI : 10.1371/journal.pone.0007164.s002

D. Fidock, T. Nomura, A. Talley, R. Cooper, S. Dzekunov et al., Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance, Molecular Cell, vol.6, issue.4, pp.861-871, 2000.
DOI : 10.1016/S1097-2765(05)00077-8

J. Zolg, J. Plitt, G. Chen, and S. Palmer, Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum, Molecular and Biochemical Parasitology, vol.36, issue.3, pp.253-262, 1989.
DOI : 10.1016/0166-6851(89)90173-4

P. Wang, M. Read, P. Sims, and J. Hyde, Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization, Molecular Microbiology, vol.23, issue.5, pp.979-986, 1997.
DOI : 10.1046/j.1365-2958.1997.2821646.x

R. Price, A. Uhlemann, A. Brockman, R. Mcready, E. Ashley et al., Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, The Lancet, vol.364, issue.9432, pp.438-447, 2004.
DOI : 10.1016/S0140-6736(04)16767-6

M. Henry, S. Alibert, E. Orlandi-pradines, H. Bogreau, T. Fusai et al., Chloroquine Resistance Reversal Agents as Promising Antimalarial Drugs, Current Drug Targets, vol.7, issue.8, pp.935-948, 2006.
DOI : 10.2174/138945006778019372
URL : http://doi.org/10.2174/138945006778019372

M. Henry, S. Alibert, C. Rogier, J. Barbe, and B. Pradines, Inhibition of Efflux of Quinolines as New Therapeutic Strategy in Malaria, Current Topics in Medicinal Chemistry, vol.8, issue.7, pp.563-578, 2008.
DOI : 10.2174/156802608783955593

H. Nagesha, G. Casey, H. Rieckmann, D. Fryauff, B. Laksana et al., New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquineresistant parasite isolates, Am J Trop Med Hyg, vol.68, pp.398-402, 2003.

D. Johnson, D. Fidock, M. Mungthin, V. Lakshmanan, A. Sidhu et al., Evidence for a Central Role for PfCRT in Conferring Plasmodium falciparum Resistance to Diverse Antimalarial Agents, Molecular Cell, vol.15, issue.6, pp.867-877, 2004.
DOI : 10.1016/j.molcel.2004.09.012

S. Picot, P. Olliaro, F. De-monbrison, A. Bienvenu, R. Price et al., A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria, Malaria Journal, vol.8, issue.1, p.89, 2009.
DOI : 10.1186/1475-2875-8-89

C. Sibley, J. Hyde, P. Sims, C. Plowe, J. Kublin et al., Pyrimethamine???sulfadoxine resistance in Plasmodium falciparum: what next?, Trends in Parasitology, vol.17, issue.12, pp.582-588, 2001.
DOI : 10.1016/S1471-4922(01)02085-2

Y. Zhang and S. Meshnick, Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs., Antimicrobial Agents and Chemotherapy, vol.35, issue.2, pp.267-271, 1991.
DOI : 10.1128/AAC.35.2.267

L. Basco and P. Ringwald, Molecular epidemiology of malaria in Yaoundé, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum

M. Duraisingh, C. Drakeley, O. Muller, R. Bailey, G. Snounou et al., Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine, Parasitology, vol.114, issue.3, pp.205-211, 1997.
DOI : 10.1017/S0031182096008487

K. Foote, . De, R. Martin, A. Oduola, K. Forsyth et al., Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum, Nature, vol.345, issue.6272, pp.255-258, 1990.
DOI : 10.1038/345255a0

M. Grobusch, I. Adagu, P. Kremsner, and D. Warhurst, Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon, Parasitology, vol.116, issue.3, pp.211-217, 1998.
DOI : 10.1017/S0031182097002266

D. Menard, F. Yapou, A. Manirakiza, D. Djalle, M. Matsika-claquin et al., Polymorphisms in pfcrt, pfmdr1, dhfr genes and in vitro responses to antimalarials in Plasmodium falciparum isolates from Bangui, Central African Republic, Am J Trop Med Hyg, vol.75, pp.381-387, 2006.

J. Marfurt, I. Muller, A. Sie, O. Oa, J. Reeder et al., The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea, Malaria Journal, vol.7, issue.1, p.61, 2008.
DOI : 10.1186/1475-2875-7-61

S. Ruetz, U. Delling, M. Brault, E. Schurr, and P. Gros, The pfmdr1 gene of Plasmodium falciparum confers cellular resistance to antimalarial drugs in yeast cells., Proceedings of the National Academy of Sciences, vol.93, issue.18, pp.9942-9947, 1996.
DOI : 10.1073/pnas.93.18.9942

M. Reed, K. Saliba, S. Caruana, K. Kirk, and A. Cowman, Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum, Nature, vol.403, pp.906-909, 2000.

D. Pillai, G. Hijar, I. Montoya, W. Marquino, T. Ruebush et al., Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru

R. Price, C. Cassar, A. Brockman, M. Duraisingh, M. Van-vugt et al., The pfmdr1 gene is associated with a multidrugresistant phenotype in Plasmodium falciparum from the Western border of Thailand, Antimicrob Agents Chemother, vol.43, pp.2943-2949, 1999.

M. Duraisingh, P. Jones, I. Sambou, L. Von-seidlein, M. Pinder et al., The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin, Molecular and Biochemical Parasitology, vol.108, issue.1, pp.13-23, 2000.
DOI : 10.1016/S0166-6851(00)00201-2

M. Duraisingh, C. Roper, D. Walliker, and D. Warhurst, Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum, Molecular Microbiology, vol.75, issue.4, pp.955-961, 2000.
DOI : 10.1016/0166-6851(93)90252-S

A. Cowman, D. Galatis, and J. Thompson, Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine., Proceedings of the National Academy of Sciences, vol.91, issue.3, pp.1143-1147, 1994.
DOI : 10.1073/pnas.91.3.1143

S. Peel, P. Bright, B. Yount, J. Handy, and R. Baric, A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro, Am J Trop Med Hyg, vol.51, pp.648-658, 1994.

P. Lim, A. Alker, N. Khim, N. Shah, S. Incardona et al., Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia, Malaria Journal, vol.8, issue.1, p.11, 2009.
DOI : 10.1186/1475-2875-8-11
URL : http://doi.org/10.1186/1475-2875-8-11

P. Phompradit, R. Wisedpanichkij, P. Muhamad, W. Chaijaroenkul, and K. Na-bangchang, Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border, Acta Tropica, vol.120, issue.1-2, pp.130-135, 2011.
DOI : 10.1016/j.actatropica.2011.07.003

A. Sidhu, A. Uhlmann, S. Valderramos, J. Valderramos, S. Krishna et al., Malaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and Artemisinin, The Journal of Infectious Diseases, vol.194, issue.4, pp.528-535, 2006.
DOI : 10.1086/507115
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978021

M. Veiga, P. Ferreira, L. Jornhagen, M. Maimberg, A. Kone et al., Novel Polymorphisms in Plasmodium falciparum ABC Transporter Genes Are Associated with Major ACT Antimalarial Drug Resistance, PLoS ONE, vol.47, issue.5, p.20212, 2011.
DOI : 10.1371/journal.pone.0020212.s003

P. Lim, T. Herdman, S. An, S. Yeung, P. Singhasivanon et al., Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, pp.455-467, 2009.

H. Noedl, Y. Se, S. Sriwichai, K. Schaecher, . Teja-isavadharm et al., Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia, Clinical Infectious Diseases, vol.51, issue.11, pp.82-89, 2010.
DOI : 10.1086/657120

H. Tinto, J. Ouédraogo, E. A. Van-overmeir, C. Dujardin, J. Van-marck et al., Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa, vivo chloroquine resistance in Burkina Faso, pp.287-292, 2003.
DOI : 10.1016/j.meegid.2003.08.002

L. Basco and P. Ringwald, Molecular epidemiology of malaria in Cameroon.X. Evaluation of Pfmdr1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives, Am J Trop Med Hyg, vol.66, pp.667-671, 2002.

P. Parola, B. Pradines, F. Simon, M. Carlotti, P. Minodier et al., Antimalarial drug susceptibility and point mutations associated with resistance in 248

A. Djimdé, O. Doumbo, J. Cortese, K. Kayentao, S. Doumbo et al., A Molecular Marker for Chloroquine-Resistant Falciparum Malaria, New England Journal of Medicine, vol.344, issue.4, pp.257-263, 2001.
DOI : 10.1056/NEJM200101253440403

M. Niang, L. Marrama, M. Ekala, A. Gaye, A. Tall et al., Accumulation of CVIET Pfcrt allele of Plasmodium falciparum in placenta of pregnant women living in an urban area of Dakar, Senegal, Journal of Antimicrobial Chemotherapy, vol.62, issue.5, pp.921-928, 2008.
DOI : 10.1093/jac/dkn299

S. Thomas, O. Ndir, T. Dieng, S. Mboup, D. Wypij et al., In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal, Am J Trop Med Hyg, vol.66, pp.474-480, 2002.

O. Sarr, A. Myrick, J. Daily, B. Diop, T. Dieng et al., In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal, Parasitology Research, vol.57, issue.Pt 3, pp.136-140, 2005.
DOI : 10.1007/s00436-005-1406-7

O. Sarr, A. Ahouidi, O. Ly, J. Daily, D. Ndiaye et al., Mutations in PFCRT K76T do not correlate with sulfadoxine???pyrimethamine???amodiaquine failure in Pikine, Senegal, Parasitology Research, vol.73, issue.4, pp.765-769, 2008.
DOI : 10.1007/s00436-008-1038-9

M. Henry, I. Diallo, J. Bordes, S. Ka, B. Pradines et al., Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg, vol.75, pp.146-151, 2006.

G. Bertin, N. Ndam, S. Jafari-guemouri, N. Fievet, E. Renart et al., High prevalence of Plasmodium falciparum pfcrt K76T mutation in pregnant women taking chloroquine prophylaxis in Senegal, Journal of Antimicrobial Chemotherapy, vol.55, issue.5, pp.788-791, 2005.
DOI : 10.1093/jac/dki097

B. Pradines, C. Rogier, T. Fusai, A. Tall, J. Trape et al., In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs, Am J Trop Med Hyg, vol.58, pp.354-357, 1998.

B. Pradines, A. Tall, D. Parzy, A. Spiegel, T. Fusai et al., In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents., Journal of Antimicrobial Chemotherapy, vol.42, issue.3, pp.333-339, 1998.
DOI : 10.1093/jac/42.3.333

B. Pradines, A. Tall, F. Ramiandrasoa, A. Spiegel, C. Sokhna et al., In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum, Journal of Antimicrobial Chemotherapy, vol.57, issue.6, pp.1093-1099, 2006.
DOI : 10.1093/jac/dkl117

B. Pradines, A. Tall, C. Rogier, A. Spiegel, J. Mosnier et al., In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs, Tropical Medicine and International Health, vol.82, issue.3, pp.265-270, 2002.
DOI : 10.1016/S0764-4469(98)80009-7

B. Fall, S. Diawara, K. Sow, E. Baret, B. Diatta et al., Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs, Malaria Journal, vol.10, issue.1, p.310, 2011.
DOI : 10.1128/AAC.45.6.1746-1750.2001

D. Ndiaye, V. Patel, A. Demas, M. Leroux, O. Ndir et al., A Non-Radioactive DAPI-based High-Throughput In Vitro Assay to Assess Plasmodium falciparum Responsiveness to Antimalarials--Increased Sensitivity of P. falciparum to Chloroquine in Senegal, American Journal of Tropical Medicine and Hygiene, vol.82, issue.2, pp.228-230, 2010.
DOI : 10.4269/ajtmh.2010.09-0470

F. Gardella, S. Assi, F. Simon, H. Bogreau, T. Eggelte et al., Antimalarial drug use in general populations of tropical Africa, Malaria Journal, vol.7, issue.1, p.124, 2008.
DOI : 10.1186/1475-2875-7-124

A. Frosch, M. Venkatesan, and M. Laufer, Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data, Malaria Journal, vol.10, issue.1, p.116, 2011.
DOI : 10.1086/655659

J. Kublin, J. Cortese, E. Njunju, R. Mukadam, J. Wirima et al., Malaria after Cessation of Chloroquine Use in Malawi, The Journal of Infectious Diseases, vol.187, issue.12, pp.1870-1875, 2003.
DOI : 10.1086/375419

M. Laufer, P. Thesing, N. Eddington, R. Masonga, F. Dzinjalamala et al., Return of Chloroquine Antimalarial Efficacy in Malawi, New England Journal of Medicine, vol.355, issue.19, pp.1959-1966, 2006.
DOI : 10.1056/NEJMoa062032

N. Noranate, R. Durand, A. Tall, L. Marrama, A. Spiegel et al., Rapid Dissemination of Plasmodium falciparum Drug Resistance Despite Strictly Controlled Antimalarial Use, PLoS ONE, vol.2, issue.1, p.139, 2007.
DOI : 10.1371/journal.pone.0000139.s003

D. Ndiaye, J. Dailly, O. Sarr, O. Ndir, O. Gaye et al., Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal, Tropical Medicine and International Health, vol.147, issue.11, pp.1176-1179, 2005.
DOI : 10.1016/S1473-3099(02)00239-6
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582373

B. Faye, M. Ndiaye, J. Ndiaye, A. A. Tine, R. et al., Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine???pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal, Parasitology Research, vol.10, issue.6, pp.133-138, 2011.
DOI : 10.1007/s00436-010-2236-9

A. Nelson, A. Purfield, P. Mcdaniel, N. Uthaimongkol, N. Buathong et al., genotyping and in vivo mefloquine resistance on the Thai-Myanmar border, Am J Trop Med Hyg, vol.72, pp.1586-592, 2005.

B. Witkowski, M. Nicolau, P. Soh, X. Iriart, S. Menard et al., Plasmodium falciparum Isolates with Increased pfmdr1 Copy Number Circulate in West Africa, Antimicrobial Agents and Chemotherapy, vol.54, issue.7, pp.3049-3051, 2010.
DOI : 10.1128/AAC.00209-10

B. Witkowski, X. Iriart, P. Soh, S. Menard, M. Alvarez et al., pfmdr1 Amplification Associated with Clinical Resistance to Mefloquine in West Africa: Implications for Efficacy of Artemisinin Combination Therapies, Journal of Clinical Microbiology, vol.48, issue.10, pp.13797-3799, 2010.
DOI : 10.1128/JCM.01057-10

G. Holmgreen, A. Bjorkman, and J. Gil, Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya, Tropical Medicine and International Health, vol.43, issue.12, pp.1808-1812, 2006.
DOI : 10.1186/1475-2875-2-31

C. Sosowath, P. Ferreira, L. Bustamante, S. Dahldtrom, A. Martensson et al., The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa, Tropical Medicine & International Health, vol.15, issue.6, pp.736-742, 2007.
DOI : 10.1111/j.1365-3156.2007.01843.x

M. Mungthin, R. Khositnithikul, N. Sitthichot, N. Suwandittakal, V. Wattanaveeradej et al., Association Between the pfmdr1 Gene and In Vitro Artemether and Lumefantrine Sensitivity in Thai Isolates of Plasmodium falciparum, American Journal of Tropical Medicine and Hygiene, vol.83, issue.5, pp.1005-1009, 2010.
DOI : 10.4269/ajtmh.2010.10-0339

B. Pradines, A. Tall, T. Fusai, A. Spiegel, R. Hienne et al., In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs, Antimicrob Agents Chemother, vol.43, pp.418-420, 1999.

B. Faye, A. Offianan, J. Ndiaye, R. Tine, W. Touré et al., Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast, Trop Med Int Health, vol.15, pp.608-613, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00767126

W. Yavo, F. B. Kuete, T. Djohan, V. Oga, S. Kassi et al., Multicentric assessment of the efficacy and tolerability of dihydroartemisininpiperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub

L. Basco, L. Bras, J. Rhoades, Z. Wilson, and C. , Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Subsaharan Africa, Molecular and Biochemical Parasitology, vol.74, issue.2, pp.157-166, 1995.
DOI : 10.1016/0166-6851(95)02492-1

N. Shah, A. Alker, R. Sem, A. Susanti, S. Muth et al., , Cambodia, Emerging Infectious Diseases, vol.14, issue.10, pp.1637-1640, 2008.
DOI : 10.3201/eid1410.080080

G. Holmgren, J. Gil, P. Ferreira, M. Veiga, C. Obonyo et al., Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y, Infection, Genetics and Evolution, vol.6, issue.4, pp.309-314, 2006.
DOI : 10.1016/j.meegid.2005.09.001

S. Nsobya, C. Dokomajilar, M. Joloba, G. Dorsey, and P. Rosenthal, Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in Uganda, Antimicrobial Agents and Chemotherapy, vol.51, issue.8, pp.3023-3025, 2007.
DOI : 10.1128/AAC.00012-07

D. Echeverry, G. Holmgren, C. Murillo, J. Higuita, J. Gil et al., Polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine, Am J Trop Med Hyg, vol.77, pp.1034-1038, 2007.

I. Danquah, B. Coulibaly, P. Meissner, I. Petruschke, O. Muller et al., Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso, Acta Tropica, vol.114, issue.1, pp.33-63, 2010.
DOI : 10.1016/j.actatropica.2009.12.008

B. Pradines, M. Mamfoumbi, M. Tall, A. Sokhna, C. Koeck et al., In Vitro Activity of Tafenoquine against the Asexual Blood Stages of Plasmodium falciparum Isolates from Gabon, Senegal, and Djibouti, vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti, pp.3225-3226, 2006.
DOI : 10.1128/AAC.00777-06

P. Agnamey, P. Brasseur, E. De-pecoulas, P. Vaillant, M. Olliaro et al., Plasmodium falciparum In Vitro Susceptibility to Antimalarial Drugs in Casamance (Southwestern Senegal) during the First 5 Years of Routine Use of Artesunate-Amodiaquine, Antimicrobial Agents and Chemotherapy, vol.50, issue.4, pp.1531-1534, 2006.
DOI : 10.1128/AAC.50.4.1531-1534.2006

J. Ndiaye, F. B. Diouf, A. Kuété, T. Cisse, M. Seck et al., Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria, Malaria Journal, vol.7, issue.1, p.16, 2008.
DOI : 10.1186/1475-2875-7-16

J. Ndiaye, M. Randrianarivelojosia, I. Sagara, P. Brasseur, I. Ndiaye et al., Randomized, multicentre assessment of the efficacy and safety of ASAQ ??? a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria, Malaria Journal, vol.8, issue.1, p.125, 2009.
DOI : 10.1186/1475-2875-8-125

H. Noedl, Y. Se, K. Schaecher, B. Smith, D. Socheat et al., Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2620, 2008.
DOI : 10.1056/NEJMc0805011

C. Sibley, K. Barnes, and C. Plowe, The rationale and plan for creating a World Antimalarial Resistance Network (WARN), Malaria Journal, vol.6, issue.1, p.118, 2007.
DOI : 10.1186/1475-2875-6-118

C. Sibley, K. Barnes, W. Watkins, and C. Plowe, A network to monitor antimalarial drug resistance: a plan for moving forward, Trends in Parasitology, vol.24, issue.1, pp.43-48, 2008.
DOI : 10.1016/j.pt.2007.09.008

. Wurtz, Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal, Malaria Journal, vol.11, issue.1, 0197.
DOI : 10.1016/j.pt.2007.09.008
URL : https://hal.archives-ouvertes.fr/pasteur-00836693